Neuroprotection during hypoxia using steroids analogues
Abstract: Hypoxic-ischemic (HI) brain injury is one of the main causes of long-term neurologic disability, morbidity and, death worldwide in adults and children. This public health concern is mainly characterized by a decrease in oxygen concentration and blood flow to the tissues, which leads to c...
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Artículo |
| Lenguaje: | Inglés |
| Publicado: |
Oxford University Press
2024
|
| Materias: | |
| Acceso en línea: | https://repositorio.uca.edu.ar/handle/123456789/18391 |
| Aporte de: |
| id |
I33-R139-123456789-18391 |
|---|---|
| record_format |
dspace |
| institution |
Universidad Católica Argentina |
| institution_str |
I-33 |
| repository_str |
R-139 |
| collection |
Repositorio Institucional de la Universidad Católica Argentina (UCA) |
| language |
Inglés |
| topic |
HIPOXIA LESION CEREBRAL DISCAPACIDAD NEUROLOGICA ASFIXIA PERINATAL MUERTE CELULAR |
| spellingShingle |
HIPOXIA LESION CEREBRAL DISCAPACIDAD NEUROLOGICA ASFIXIA PERINATAL MUERTE CELULAR Toro-Urrego, Nicolás Kobiec, Tamara Bordet, Sofía Otero Losada, Matilde Mardaraz, Claudia Meloni, Camila Kusnier, Carlos F. Kölliker-Frers, Rodolfo A. Luaces, Juan Pablo Capani, Francisco Neuroprotection during hypoxia using steroids analogues |
| topic_facet |
HIPOXIA LESION CEREBRAL DISCAPACIDAD NEUROLOGICA ASFIXIA PERINATAL MUERTE CELULAR |
| description |
Abstract: Hypoxic-ischemic (HI) brain injury is one of the main causes of long-term neurologic disability, morbidity and, death worldwide
in adults and children. This public health concern is mainly characterized by a decrease in oxygen concentration and blood flow to
the tissues, which leads to cell death by energy depletion and increases free radical generation and inflammation, caused by an
inefficient supply of nutrients to the brain. Hypoxic-ischemic brain injury occurs in perinatal asphyxia (PA) [1, 2]. This clinical
condition is characterized by oxygen supply suspension before, during, or immediately after birth and it is an important risk factor
for neurodevelopmental damage. Its estimated 1/1000 live births incidence in developed countries rises from FIVE to TENfold in
developing countries. Neuroactive steroids like selective estrogen receptor modulators, SERMs, exert several neuroprotective effects
in different pathological scenarios. These include a decrease in reactive oxygen species, mitochondrial survival, and maintenance
of cell viability. In this context, these neurosteroids constitute promising molecules, which could modify brain response to
injury. To replicate the conditions that occur in the presence of deprivation or decrease in O2 and glucose levels several studies
have proposed a model of O2 and glucose deprivation (OGD) [2]. For this study T98G cells were seeded onto 24-well plates in
DMEM culture medium containing 10% FBS at a seeding density of 10,000 cells per well and incubated for 2–3 days until they
reach confluence. Subsequently, the medium was changed to glucose-free DMEM, and then incubated in 1% O2 in a hypoxia
incubator (Hypoxia Incubator Chamber, STEMCELL) for 9 hours. This was followed by reperfusion by changing the media
to high glucoseDMEMsupplemented with 10% FBS and transferring the cells to 37°C in 95% air/5% CO2 in normal conditions,
the control group was maintained in normal conditions of O2 and glucose during the experiment. For drug treatments, cell cultures
were incubated inDMEMserum-free medium containing 10 and 100nMRaloxifene and Tibolone, as co-treatment ofOGD
and reperfusion. Cell viability and morphology are tightly related, and increases in oxidative stress, lipid peroxidation, and
changes in the mitochondrial membrane potential usually induce noticeable morphological changes. Determination of
Mitochondrial Mass and mitochondrial membrane potential was evaluated using Nonyl acridine orange (NAO) and
Tetramethyl Rhodamine Methyl Ester (TMRM) respectively by flow cytometry and fluorescence intensity. After treatments
were completed, cells were loaded in the dark with 5 μM NAO at 37°C for 20 min. Thereafter, cells were washed with PBS to
eliminate all non-sequestered dye. DIC and fluorescence images were obtained with NIKON - Eclipse Ti-E PFS microscope.
The analysis of cellular fluorescence was performed using Fiji. The microphotographs were loaded, and background signals
were eliminated from the images. Subsequently, 50 cells were randomly selected using a numbered grid in each microphotograph.
The mean fluorescence value of the 50 cells was determined in eight microphotographs for each treatment using the Measure algorithm
of Fiji and selecting each cell manually via ROI’s (Regions of Interest) Management. There were no variations in the conditions
of the image processing. Each assay was performed with a minimum of six replicate wells for each condition and
experiments were repeated three times. Qualitative results suggested that OGD may induce morphological changes, cells showed
smaller cell bodies and fewer cellular processes than control cells. Raloxifene and tibolone preserved cell morphology even in cells
exposed to OGD. Assays showed a significant viability reduction on cells exposed to OGD, cells co-treated with 100 and 10 nM
raloxifene and 100 nM tibolone showed a 65,34%(p= 0,0021), 70,56%(p <0,0001) and 66,49%(p= 0,0013) increase in cell
viability when compared to OGD cells, respectively. Regarding lipid peroxidation, the assay showed a significant preservation of
mitochondrial mass using a cotreatment of Raloxifene 100 nM (p= 0,0178) and 10nM (p=0.0014). On the other hand, Tibolone
10 nM (p= 0,0137) cotreatment preserves significantly mitochondrial membrane potential in cells exposed to OGD/reperfusion.
Our results suggest that raloxifene and tibolone exert protective effects in human T98G glial cells exposed to OGD/reperfusion
through the reduction of lipid peroxidation, the preservation of mitochondrial membrane potential and viability, which altogether counteract the cell damage in our model. |
| format |
Artículo |
| author |
Toro-Urrego, Nicolás Kobiec, Tamara Bordet, Sofía Otero Losada, Matilde Mardaraz, Claudia Meloni, Camila Kusnier, Carlos F. Kölliker-Frers, Rodolfo A. Luaces, Juan Pablo Capani, Francisco |
| author_facet |
Toro-Urrego, Nicolás Kobiec, Tamara Bordet, Sofía Otero Losada, Matilde Mardaraz, Claudia Meloni, Camila Kusnier, Carlos F. Kölliker-Frers, Rodolfo A. Luaces, Juan Pablo Capani, Francisco |
| author_sort |
Toro-Urrego, Nicolás |
| title |
Neuroprotection during hypoxia using steroids analogues |
| title_short |
Neuroprotection during hypoxia using steroids analogues |
| title_full |
Neuroprotection during hypoxia using steroids analogues |
| title_fullStr |
Neuroprotection during hypoxia using steroids analogues |
| title_full_unstemmed |
Neuroprotection during hypoxia using steroids analogues |
| title_sort |
neuroprotection during hypoxia using steroids analogues |
| publisher |
Oxford University Press |
| publishDate |
2024 |
| url |
https://repositorio.uca.edu.ar/handle/123456789/18391 |
| work_keys_str_mv |
AT torourregonicolas neuroprotectionduringhypoxiausingsteroidsanalogues AT kobiectamara neuroprotectionduringhypoxiausingsteroidsanalogues AT bordetsofia neuroprotectionduringhypoxiausingsteroidsanalogues AT oterolosadamatilde neuroprotectionduringhypoxiausingsteroidsanalogues AT mardarazclaudia neuroprotectionduringhypoxiausingsteroidsanalogues AT melonicamila neuroprotectionduringhypoxiausingsteroidsanalogues AT kusniercarlosf neuroprotectionduringhypoxiausingsteroidsanalogues AT kollikerfrersrodolfoa neuroprotectionduringhypoxiausingsteroidsanalogues AT luacesjuanpablo neuroprotectionduringhypoxiausingsteroidsanalogues AT capanifrancisco neuroprotectionduringhypoxiausingsteroidsanalogues |
| _version_ |
1807949584708665344 |
| spelling |
I33-R139-123456789-183912024-07-06T05:01:22Z Neuroprotection during hypoxia using steroids analogues Toro-Urrego, Nicolás Kobiec, Tamara Bordet, Sofía Otero Losada, Matilde Mardaraz, Claudia Meloni, Camila Kusnier, Carlos F. Kölliker-Frers, Rodolfo A. Luaces, Juan Pablo Capani, Francisco HIPOXIA LESION CEREBRAL DISCAPACIDAD NEUROLOGICA ASFIXIA PERINATAL MUERTE CELULAR Abstract: Hypoxic-ischemic (HI) brain injury is one of the main causes of long-term neurologic disability, morbidity and, death worldwide in adults and children. This public health concern is mainly characterized by a decrease in oxygen concentration and blood flow to the tissues, which leads to cell death by energy depletion and increases free radical generation and inflammation, caused by an inefficient supply of nutrients to the brain. Hypoxic-ischemic brain injury occurs in perinatal asphyxia (PA) [1, 2]. This clinical condition is characterized by oxygen supply suspension before, during, or immediately after birth and it is an important risk factor for neurodevelopmental damage. Its estimated 1/1000 live births incidence in developed countries rises from FIVE to TENfold in developing countries. Neuroactive steroids like selective estrogen receptor modulators, SERMs, exert several neuroprotective effects in different pathological scenarios. These include a decrease in reactive oxygen species, mitochondrial survival, and maintenance of cell viability. In this context, these neurosteroids constitute promising molecules, which could modify brain response to injury. To replicate the conditions that occur in the presence of deprivation or decrease in O2 and glucose levels several studies have proposed a model of O2 and glucose deprivation (OGD) [2]. For this study T98G cells were seeded onto 24-well plates in DMEM culture medium containing 10% FBS at a seeding density of 10,000 cells per well and incubated for 2–3 days until they reach confluence. Subsequently, the medium was changed to glucose-free DMEM, and then incubated in 1% O2 in a hypoxia incubator (Hypoxia Incubator Chamber, STEMCELL) for 9 hours. This was followed by reperfusion by changing the media to high glucoseDMEMsupplemented with 10% FBS and transferring the cells to 37°C in 95% air/5% CO2 in normal conditions, the control group was maintained in normal conditions of O2 and glucose during the experiment. For drug treatments, cell cultures were incubated inDMEMserum-free medium containing 10 and 100nMRaloxifene and Tibolone, as co-treatment ofOGD and reperfusion. Cell viability and morphology are tightly related, and increases in oxidative stress, lipid peroxidation, and changes in the mitochondrial membrane potential usually induce noticeable morphological changes. Determination of Mitochondrial Mass and mitochondrial membrane potential was evaluated using Nonyl acridine orange (NAO) and Tetramethyl Rhodamine Methyl Ester (TMRM) respectively by flow cytometry and fluorescence intensity. After treatments were completed, cells were loaded in the dark with 5 μM NAO at 37°C for 20 min. Thereafter, cells were washed with PBS to eliminate all non-sequestered dye. DIC and fluorescence images were obtained with NIKON - Eclipse Ti-E PFS microscope. The analysis of cellular fluorescence was performed using Fiji. The microphotographs were loaded, and background signals were eliminated from the images. Subsequently, 50 cells were randomly selected using a numbered grid in each microphotograph. The mean fluorescence value of the 50 cells was determined in eight microphotographs for each treatment using the Measure algorithm of Fiji and selecting each cell manually via ROI’s (Regions of Interest) Management. There were no variations in the conditions of the image processing. Each assay was performed with a minimum of six replicate wells for each condition and experiments were repeated three times. Qualitative results suggested that OGD may induce morphological changes, cells showed smaller cell bodies and fewer cellular processes than control cells. Raloxifene and tibolone preserved cell morphology even in cells exposed to OGD. Assays showed a significant viability reduction on cells exposed to OGD, cells co-treated with 100 and 10 nM raloxifene and 100 nM tibolone showed a 65,34%(p= 0,0021), 70,56%(p <0,0001) and 66,49%(p= 0,0013) increase in cell viability when compared to OGD cells, respectively. Regarding lipid peroxidation, the assay showed a significant preservation of mitochondrial mass using a cotreatment of Raloxifene 100 nM (p= 0,0178) and 10nM (p=0.0014). On the other hand, Tibolone 10 nM (p= 0,0137) cotreatment preserves significantly mitochondrial membrane potential in cells exposed to OGD/reperfusion. Our results suggest that raloxifene and tibolone exert protective effects in human T98G glial cells exposed to OGD/reperfusion through the reduction of lipid peroxidation, the preservation of mitochondrial membrane potential and viability, which altogether counteract the cell damage in our model. 2024-07-05T12:59:48Z 2024-07-05T12:59:48Z 2023 Artículo Capani, F. et al. Neuroprotection during hypoxia using steroids analogues [en línea]. Microscopy and Microanalysis. 2023, 29(1). doi: 10.1093/micmic/ozad067.583. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/18391 1431-9276 (impreso) 1435-8115 (online) https://repositorio.uca.edu.ar/handle/123456789/18391 10.1093/micmic/ozad067.583 eng Acceso abierto http://creativecommons.org/licenses/by-nc-sa/4.0/ application/pdf Oxford University Press Microscopy and Microanalysis. 2023, 29(1) |